Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2015 May 1;69(1):52–60. doi: 10.1097/QAI.0000000000000549

Figure 4. Trends in mean levels of plasma biomarkers of macrophage and lymphocyte activation.

Figure 4

Panels show levels of sCD14 levels (ng/ml) (panel A), sCD27 levels (U/ml) (panel B) and sCD163 levels (ng/ml) (panel C). The horizontal red line indicates mean values. Significant changes between baseline and 48 weeks in HIV+ subjects are represented with * (p<0.05, Wilcoxon Rank-Sum test). Significant differences between HIV+ subjects and HIV− controls are shown with † (p<0.05, Wilcoxon Rank-Sum test).